Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

VYNE Therapeutics Announces Biomarker Data From Phase 1b Trial Of VYN201 For Treatment Of Vitiligo

Author: Benzinga Newsdesk | January 10, 2024 09:04am

VYN201 demonstrated positive effect on key biomarkers relevant to vitiligo
Data supports VYN201's rapid onset of action and previously announced positive clinical results
- Program is on track for Phase 2b initiation in Q2

Posted In: VYNE